天新药业
(603235)
| 流通市值：40.35亿 | | | 总市值：120.13亿 |
| 流通股本：1.47亿 | | | 总股本：4.38亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 2,379,812,588.34 | 2,307,830,751.93 | 2,399,614,715.56 | 2,363,328,253.22 |
| 应收票据及应收账款 | 323,815,947.54 | 281,051,321.82 | 206,044,590.86 | 323,829,907.97 |
| 其中：应收票据 | 58,807,037.57 | 53,292,563.09 | 39,387,914.78 | 74,486,588.46 |
| 应收账款 | 265,008,909.97 | 227,758,758.73 | 166,656,676.08 | 249,343,319.51 |
| 应收款项融资 | 27,406,483.28 | 3,292,184.01 | 19,015,638.41 | 19,684,220.71 |
| 预付款项 | 45,005,934.29 | 22,056,580.75 | 31,007,739.25 | 11,858,213.21 |
| 其他应收款合计 | 2,294,957.87 | 1,702,193.2 | 2,188,433.27 | 2,199,424.35 |
| 存货 | 434,430,379.01 | 478,965,233.63 | 357,240,580.03 | 397,343,495.17 |
| 其他流动资产 | 23,817,411.68 | 26,413,558.21 | 14,507,838.96 | 7,966,357.8 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,236,583,702.01 | 3,121,311,823.55 | 3,029,619,536.34 | 3,126,209,872.43 |
| 非流动资产: | | | | |
| 长期股权投资 | 25,145.26 | 25,145.26 | 52,587.98 | 43,343.76 |
| 固定资产 | 1,219,821,427.73 | 1,175,371,801.24 | 1,161,437,067.06 | 1,153,548,267.87 |
| 在建工程 | 408,105,078.79 | 435,368,164.72 | 263,327,771.11 | 190,737,514.27 |
| 使用权资产 | 6,878,678.62 | 7,604,378.64 | 4,976,579.1 | 5,854,482.17 |
| 无形资产 | 191,454,527.43 | 192,311,293.45 | 193,009,706.02 | 194,843,819.93 |
| 长期待摊费用 | 10,646,732.27 | 10,993,191.53 | 11,339,650.79 | 11,686,110.05 |
| 递延所得税资产 | 80,195,647.31 | 81,125,270.93 | 62,625,906.34 | 64,770,784.49 |
| 其他非流动资产 | 95,900,236.27 | 66,048,109.02 | 99,568,083.97 | 61,674,158.12 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,013,027,473.68 | 1,968,847,354.79 | 1,796,337,352.37 | 1,683,158,480.66 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,249,611,175.69 | 5,090,159,178.34 | 4,825,956,888.71 | 4,809,368,353.09 |
| 流动负债: | | | | |
| 短期借款 | 220,014,666.67 | 100,072,222.22 | 100,000,000 | 100,065,000 |
| 应付票据及应付账款 | 117,858,302.37 | 138,069,304.85 | 88,642,704.63 | 70,058,333.62 |
| 其中：应付票据 | 26,480,000 | 11,430,000 | - | - |
| 应付账款 | 91,378,302.37 | 126,639,304.85 | 88,642,704.63 | 70,058,333.62 |
| 合同负债 | 23,145,159.28 | 21,098,771.55 | 14,784,679.36 | 14,188,085.67 |
| 应付职工薪酬 | 37,076,237.97 | 104,987,763.19 | 69,225,487.62 | 54,777,450.21 |
| 应交税费 | 43,851,113.97 | 33,890,925.82 | 20,207,184.57 | 74,764,297.8 |
| 其他应付款合计 | 19,540,826.18 | 8,578,504.58 | 5,556,376.49 | 7,584,081.24 |
| 一年内到期的非流动负债 | 2,976,222.84 | 3,123,735.24 | 2,014,247.79 | 2,560,847.32 |
| 其他流动负债 | 44,425,035.58 | 51,506,813.5 | 18,099,293.24 | 56,479,279.34 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 508,887,564.86 | 461,328,040.95 | 318,529,973.7 | 380,477,375.2 |
| 非流动负债: | | | | |
| 租赁负债 | 4,482,375.85 | 5,095,912.47 | 3,510,750.14 | 3,821,230.1 |
| 递延收益 | 381,678,554 | 390,788,063.48 | 336,403,319.32 | 342,987,736.21 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 386,160,929.85 | 395,883,975.95 | 339,914,069.46 | 346,808,966.31 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 895,048,494.71 | 857,212,016.9 | 658,444,043.16 | 727,286,341.51 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 437,780,000 | 437,780,000 | 437,780,000 | 437,780,000 |
| 资本公积 | 1,989,385,337.74 | 1,986,901,331.97 | 1,984,417,326.2 | 1,981,933,320.43 |
| 减:库存股 | 28,417,490.56 | - | - | - |
| 盈余公积 | 218,890,000 | 218,890,000 | 218,890,000 | 218,890,000 |
| 未分配利润 | 1,736,924,833.8 | 1,589,375,829.47 | 1,526,425,519.35 | 1,443,478,691.15 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,354,562,680.98 | 4,232,947,161.44 | 4,167,512,845.55 | 4,082,082,011.58 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,354,562,680.98 | 4,232,947,161.44 | 4,167,512,845.55 | 4,082,082,011.58 |
| 负债和股东权益合计 | 5,249,611,175.69 | 5,090,159,178.34 | 4,825,956,888.71 | 4,809,368,353.09 |
| 公告日期 | 2024-04-30 | 2024-04-24 | 2023-10-31 | 2023-08-26 |
| 审计意见(境内) | | 标准无保留意见 | | |